Rhenman & Partners Asset Management AB VRTX Holdings History
Rhenman & Partners Asset Management AB's Vertex Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Rhenman & Partners Asset Management AB held 66,750.00 shares of Vertex Pharmaceuticals Inc(VRTX), totaling $32.36 Mil. This investment constitutes 3.72% of their stock portfolio, and Rhenman & Partners Asset Management AB now holds 0.03% of the outstanding Vertex Pharmaceuticals Inc(VRTX) stock.
The initial trade took place in 2014Q2. And since then Rhenman & Partners Asset Management AB has made 18 purchases of VRTX, at an average price of $180.68, for a total of 513,072.00 shares. In addition, there have been 16 sales at an average price of $222.82 for 446,322.00 shares. Based on historical transaction data and VRTX's current price of $459.81, Rhenman & Partners Asset Management AB's estimated gain on his VRTX holdings is $37.44 Mil, reflecting a 40.39% gain to date.
Rhenman & Partners Asset Management AB VRTX ($459.81) Holding Chart
Rhenman & Partners Asset Management AB VRTX ($459.81) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
